Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
EMBO Molecular Medicine|February 17, 2018
Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancerAzhar Ali, Elena Levantini, Jun Ting Teo, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 8, 2023
Toker Cell Hyperplasia in the Nipple-Areolar Complex of Transmasculine IndividualsGabrielle M Baker, Vanessa C Bret-Mounet, Jingxiong Xu, et al.Cancer Discovery|April 18, 2015
In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at EndosomesChen Li Chew, Andrea Lunardi, Federico Gulluni, et al.Molecular Cancer Therapeutics|December 5, 2020
Cabozantinib Unlocks Efficient In Vivo Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate TumorsKiranj Kishor Chaudagar, Natalie Landon-Brace, Aniruddh Solanki, et al.The Journal of Clinical Investigation|December 15, 2021
WWP1 inactivation enhances efficacy of PI3K inhibitors while suppressing their toxicities in breast cancer modelsTakahiro Kishikawa, Hiroshi Higuchi, Limei Wang, et al.Theranostics|March 21, 2020
Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitorsTan-Min Chin, Gandhi T K Boopathy, Ellen P S Man, et al.Cell Research|January 9, 2020
Author Correction: Intragenic antagonistic roles of protein and circRNA in tumorigenesisJlenia Guarnerio, Yang Zhang, Giulia Cheloni, et al.Nature|July 27, 2022
PI3K drives the de novo synthesis of coenzyme A from vitamin B5Christian C Dibble, Samuel A Barritt, Grace E Perry, et al.Cell Research|June 19, 2019
Intragenic antagonistic roles of protein and circRNA in tumorigenesisJlenia Guarnerio, Yang Zhang, Giulia Cheloni, et al.Cancer Research|July 18, 2024
Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast CancerAlissandra L Hillis, Timothy D Martin, Haley E Manchester, et al.Pageof 6